The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Clearly lack of liquidity in the market. Even if you want to sell, for some strange reason, it is best to hold onto your shares and get the MM to step up the price.
Looking at the sequence it appears that £14.2k (100,000 share) purchase took quite a while to fill, so activity was taking place around it. I am surprised, as it was not much larger than the 82,000 share purchase but maybe that combination caused the problem (or possible successful rise).
Perhaps there is a large buy order in and they are frantically accumulating sales to make it up. I will watch with baited breath.
"Harvest Minerals Limited, the AIM listed remineraliser producer, is pleased to announce that it has acquired at nominal value the mineral rights over an area ('the Project') highly prospective for the exploration of agriculture limestone, a critical soil input used to neutralise soil acidity by raising its pH levels. Located in the municipality of Iguatama, Minas Gerais, the Project is approximately 168km from Harvest's Arapuá Fertiliser Project ('Arapuá')."
EmeraldCarrots, here is the article you meant to post:
https://www.reuters.com/world/india/india-considers-buying-discounted-russian-oil-commodities-officials-say-2022-03-14/
The problem that India has is their weapons are largely supplied by the Russians and they need servicing, so India and Russia are compelled to have a close relationship, no matter how unpalatable that may be. You will see that India and looking at buying other commodities at discounted prices. As we have all known, owning CNE, India no matter what regime is in charge, have the morals of a sewer but they will pay a price. I will not knowingly invest my money there again., though I am sure Mr Modi won't lose any sleep over that.
Groover, the answer to your question is sort of. From what I understand the Russians mine the ore in the Murmansk area and ship it to Perm, in central Russia. They do not have the sophistication to process to the end product, so they then ship this material off to Estonia for final processing. As with a lot of operations this likely to have been a throw back to the Soviet days. Putin back in the early 2010's identified Rare Earths as a key element to his military machine and a number of operations from the Black Sea (near Georgia) and Siberia were to be explored as potential sources. At last accounting I think Russia accounted for less than 2% of the world output and as I have said they don't appear to take it to the final processing.
What you need to realise is that the old soviet railway runs from the potash mine in Belarus through Lithuania, to the port on the Baltic coast. The line is almost solely dedicated for this purpose. Lithuania not only is in the EU it also in NATO so have imposed the restriction, as part of the wider embargo. Potash supplies are available from Spain, Britain, Israel, Jordan and Canada to name but a few but probably at increased costs. It is likely that Brazilian distributors have entered long term contract with the Belarus company.
This is great news for HMI.
HMI have the double benefit of the terrible war in the Ukraine, refocusing the importance of Brazil as an agricultural exporter, coupled to the rise in natural gas costs driving up fertiliser costs. HMI is in that exclusive club of drivers to address both issues indirectly and directly.
Not if we look over 5 years!
The delay is due to the US shareholders, so that they are not at an undue disadvantage.
Results were solid. Growth was as largely predicted. The one good element was the acquisition of BioVision is showing sound reasoning, with a growth rate higher than the existing portfolio.
Planned 2024 performance is inline with expectations, despite the Covid impact that has affected customers over the last 21 months.
Hoping to see a rise from here.
Denby, I do hope so. As they have switched their annual reporting from June to December, it was important to understand Abcam's progress, especially after the acquisition of BioVision.
If an RNS, for half year results, is to come today it is likely to be for the NY stock exchange opening. Let us see at 13.30.
More news is being published of the partnership between Abcam and Alamar. If successful it should advance life science, offer early detection to cancers and other diseases and increase life expectancy for all of us. Clearly on the back of this there will be massive opportunities to sell more biochemical materials. It is good to see Abcam using their expertise and solutions with other R & D expert partners:
https://www.businessweekly.co.uk/news/biomedtech/abcam-and-alamar-probe-human-proteome
So surprised today to see the SP drop, so much, especially as the market is up.
JP Morgan increased their price target to 1800p, first thing this morning and now I see that ABC are entering into a partnership with Alamar Biosciences, for blood testing of cancer and other diseases. This I see as a significant growth opportunity. Why no RNS for this is perhaps unusual.
https://www.streetinsider.com/Corporate+News/Abcam+plc+%28ABCM%29+Partners+with+Alamar+for+Further+Understanding+of+Human+Proteome/19412812.html
Anglo American have finally moved Chris Fraser from that lead role on Woodsmith. Having been a small investor in Sirius I watched in horror how this individual not only survived but benefited from the poor way he managed the process. The problems continued after the Anglo American take over.
It is good to see that AAL have assessed his role, failings and brought in an individual who has delivered and excelled in another part of the business. Great move by Anglo!
Pete, if you got 29.7p that means you got 1% more than I did within the HL ISA. My income works out at 29.4p.
What was proving to be a concern over tax, turned into the speed of our platforms and now I see how varied amounts received.
I received what appears to be the full amount within the HL ISA. When I multiplied my shares by 39.4 cents and put that into an online conversion tool I was about 0.7% short. Hope that helps you Jeff.
The BBC have reported that the new variant has been discovered in Belgium. If it has got to those 3 places, outside of Africa we can expect that other cases are also present elsewhere.
Apparently it will take some Pharmaceutical companies 2 weeks to assess the ability of their vaccines to combat the new strain.
The variant has also been discovered in Hong Kong and Israel, though I believe these are single cases.
Good to see Unilever being only slightly down, when the FTSE 100 is presently 3.3% down.
Within a Covid variant cloud there is a silver lining and today that is Abcam. A number of my shares are down and some seriously down. The benefits and downside of hedging with a diverse portfolio. I don't reap the rewards when sectors rise but I also don't get the hammering when sectors fall.
There is no news and no indicators as to why Abcam is up and all I can think of is the ongoing need to carry out research through the ongoing crisis. At the core of this are the materials supplied by Abcam.